Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
NCT: NCT03022708 · ACTIVE_NOT_RECRUITING
Brief Summary
This is a multi-center prospective, single-arm, non-randomized, pivotal study that will continue to access the feasibility of the Xeltis Bioabsorbable Pulmonary Valved Conduit in subjects requiring right ventricular outflow tract correction or reconstruction due to congenital heart malformations.
Frequently Asked Questions
What is Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study?
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study is a clinical trial registered under NCT03022708. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03022708?
The current status of NCT03022708 (Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study) is: ACTIVE_NOT_RECRUITING.
When did Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study start?
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study started on 2017-05-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.